Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNA Plant Technology (DNAP) was a pioneering agricultural biotechnology company founded in 1981, specializing in the development of premium plant varieties through advanced breeding and genetic engineering. The company was a leader in the early ag-biotech movement, utilizing proprietary techniques like somaclonal variation to improve traits such as flavor, texture, and shelf-life in produce. DNAP is well-known for its "VegiSnax" brand of snack-sized vegetables and its efforts to commercialize genetically modified crops, including high-solids tomatoes. Following a merger with the Mexican conglomerate Savia in 1996, the company's operations were eventually absorbed into larger industry players like Seminis and Monsanto. Its legacy remains as one of the first firms to bridge the gap between laboratory biotechnology and the consumer produce market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DNA Plant Technologies.